[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Narcolepsy Treatment Market Size study, by Drug Type (Vasopressors, CNS Stimulants, Decongestants, Serotonin Reuptake Inhibitors), by End-Use (Retail Pharmacies, Drug Stores, E-commerce) and Regional Forecasts 2022-2028

April 2022 | 200 pages | ID: G9389A9A2909EN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Narcolepsy Treatment Market is valued at approximately USD 4.10 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.00 % over the forecast period 2022-2028. Narcolepsy is a chronic neurological disorder that is associated with Excessive Daytime Sleepiness (EDS), hypnagogic hallucinations, cataplexy, sleep paralysis, and fragmented night sleep. It is the brain’s inability to control sleep-wake cycles. The high disease burden of sleep-related disorders over the globe and acquisition of biopharmaceutical companies has led to the adoption of Narcolepsy Treatment across the forecast period. For Instance: In January 2020, Axsome Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, entered into an agreement with Pfizer Inc. for an exclusive U.S. license to Pfizer’s clinical and nonclinical data, and intellectual property for reboxetine, the active pharmaceutical ingredient in AXS-12 which Axsome is developing for the treatment of narcolepsy. Also, with the growing research and development activities to find a cure for narcolepsy and narcolepsy awareness programs and services, the adoption & demand for Narcolepsy Treatment is likely to increase the market growth during the forecast period. However, low awareness among patients and adverse effects and risks related to narcolepsy drugs impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Narcolepsy Treatment Market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the advanced healthcare systems in the region and rising efforts by various organizations to spread awareness among the general population. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as high prevalence of the disorder and relatively less awareness among the general population in terms of the symptoms associated with narcolepsy would create lucrative growth prospects for the Narcolepsy Treatment market across Asia-Pacific region.

Major market players included in this report are:
Addrenex pharmaceuticals, inc.
Jazz pharmaceuticals plc
Graymark healthcare, inc.
Teva pharmaceutical industries ltd.
Arena pharmaceuticals, inc.
Bioprojet
Shire
Ligand pharmaceuticals, inc.
Western bio vegetable seed
Maharashtra hybrid seeds company private limited

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Type:
Vasopressors
CNS Stimulants
Decongestants
Serotonin Reuptake Inhibitors
By End-Use:
Retail Pharmacies
Drug Stores
E-commerce
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Narcolepsy Treatment Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
  1.2.1. Narcolepsy Treatment Market, by Region, 2020-2028 (USD Billion)
  1.2.2. Narcolepsy Treatment Market, by Drug Type, 2020-2028 (USD Billion)
  1.2.3. Narcolepsy Treatment Market, by End-Use, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. GLOBAL NARCOLEPSY TREATMENT MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Scope of the Study
  2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. GLOBAL NARCOLEPSY TREATMENT MARKET DYNAMICS

3.1. Narcolepsy Treatment Market Impact Analysis (2020-2028)
  3.1.1. Market Drivers
    3.1.1.1. High disease burden of sleep-related disorders over the globe
    3.1.1.2. Acquisition of biopharmaceutical companies
  3.1.2. Market Challenges
    3.1.2.1. Low awareness among patients
    3.1.2.2. Adverse effects and risks related to narcolepsy drugs
  3.1.3. Market Opportunities
    3.1.3.1. Growing research and development activities to find a cure for narcolepsy
    3.1.3.2. Narcolepsy awareness programs and services

CHAPTER 4. GLOBAL NARCOLEPSY TREATMENT MARKET INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
  4.2.1. Political
  4.2.2. Economical
  4.2.3. Social
  4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies

CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT

  5.1.1. Assessment of the overall impact of COVID-19 on the industry
  5.1.2. Pre COVID-19 and post COVID-19 market scenario

CHAPTER 6. GLOBAL NARCOLEPSY TREATMENT MARKET, BY DRUG TYPE

6.1. Market Snapshot
6.2. Global Narcolepsy Treatment Market by Drug Type, Performance - Potential Analysis
6.3. Global Narcolepsy Treatment Market Estimates & Forecasts by Drug Type, 2019-2028 (USD Billion)
6.4. Narcolepsy Treatment Market, Sub Segment Analysis
  6.4.1. Vasopressors
  6.4.2. CNS Stimulants
  6.4.3. Decongestants
  6.4.4. Serotonin Reuptake Inhibitors

CHAPTER 7. GLOBAL NARCOLEPSY TREATMENT MARKET, BY END-USE

7.1. Market Snapshot
7.2. Global Narcolepsy Treatment Market by End-Use, Performance - Potential Analysis
7.3. Global Narcolepsy Treatment Market Estimates & Forecasts by End-Use, 2019-2028 (USD Billion)
7.4. Narcolepsy Treatment Market, Sub Segment Analysis
  7.4.1. Retail Pharmacies
  7.4.2. Drug Stores
  7.4.3. E-commerce

CHAPTER 8. GLOBAL NARCOLEPSY TREATMENT MARKET, REGIONAL ANALYSIS

8.1. Narcolepsy Treatment Market, Regional Market Snapshot
8.2. North America Narcolepsy Treatment Market
  8.2.1. U.S. Narcolepsy Treatment Market
    8.2.1.1. Drug Type breakdown estimates & forecasts, 2019-2028
    8.2.1.2. End-Use breakdown estimates & forecasts, 2019-2028
  8.2.2. Canada Narcolepsy Treatment Market
8.3. Europe Narcolepsy Treatment Market Snapshot
  8.3.1. U.K. Narcolepsy Treatment Market
  8.3.2. Germany Narcolepsy Treatment Market
  8.3.3. France Narcolepsy Treatment Market
  8.3.4. Spain Narcolepsy Treatment Market
  8.3.5. Italy Narcolepsy Treatment Market
  8.3.6. Rest of Europe Narcolepsy Treatment Market
8.4. Asia-Pacific Narcolepsy Treatment Market Snapshot
  8.4.1. China Narcolepsy Treatment Market
  8.4.2. India Narcolepsy Treatment Market
  8.4.3. Japan Narcolepsy Treatment Market
  8.4.4. Australia Narcolepsy Treatment Market
  8.4.5. South Korea Narcolepsy Treatment Market
  8.4.6. Rest of Asia Pacific Narcolepsy Treatment Market
8.5. Latin America Narcolepsy Treatment Market Snapshot
  8.5.1. Brazil Narcolepsy Treatment Market
  8.5.2. Mexico Narcolepsy Treatment Market
8.6. Rest of The World Narcolepsy Treatment Market

CHAPTER 9. COMPETITIVE INTELLIGENCE

9.1. Top Market Strategies
9.2. Company Profiles
  9.2.1. Addrenex pharmaceuticals, inc.
    9.2.1.1. Key information
    9.2.1.2. Overview
    9.2.1.3. Financial (subject to data availability)
    9.2.1.4. Product summary
    9.2.1.5. Recent developments
  9.2.2. Jazz pharmaceuticals plc
  9.2.3. Graymark healthcare, inc.
  9.2.4. Teva pharmaceutical industries ltd.
  9.2.5. Arena pharmaceuticals, inc.
  9.2.6. Bioprojet
  9.2.7. Shire
  9.2.8. Ligand pharmaceuticals, inc.
  9.2.9. Western bio vegetable seed
  9.2.10. Maharashtra hybrid seeds company private limited

CHAPTER 10. RESEARCH PROCESS

10.1. Research Process
  10.1.1. Data Mining
  10.1.2. Analysis
  10.1.3. Market Estimation
  10.1.4. Validation
  10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Narcolepsy Treatment market, report scope
TABLE 2. Global Narcolepsy Treatment market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global Narcolepsy Treatment market estimates & forecasts by Drug Type 2019-2028 (USD Billion)
TABLE 4. Global Narcolepsy Treatment market estimates & forecasts by End-Use 2019-2028 (USD Billion)
TABLE 5. Global Narcolepsy Treatment market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 6. Global Narcolepsy Treatment market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 7. Global Narcolepsy Treatment market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 8. Global Narcolepsy Treatment market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global Narcolepsy Treatment market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global Narcolepsy Treatment market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Narcolepsy Treatment market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Narcolepsy Treatment market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Narcolepsy Treatment market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Narcolepsy Treatment market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. U.S. Narcolepsy Treatment market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. U.S. Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 17. U.S. Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 18. Canada Narcolepsy Treatment market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 19. Canada Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 20. Canada Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 21. UK Narcolepsy Treatment market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 22. UK Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 23. UK Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 24. Germany Narcolepsy Treatment market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 25. Germany Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 26. Germany Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 27. RoE Narcolepsy Treatment market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 28. RoE Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 29. RoE Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 30. China Narcolepsy Treatment market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 31. China Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 32. China Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 33. India Narcolepsy Treatment market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 34. India Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 35. India Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 36. Japan Narcolepsy Treatment market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 37. Japan Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 38. Japan Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 39. RoAPAC Narcolepsy Treatment market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 40. RoAPAC Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 41. RoAPAC Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 42. Brazil Narcolepsy Treatment market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 43. Brazil Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 44. Brazil Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 45. Mexico Narcolepsy Treatment market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 46. Mexico Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 47. Mexico Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 48. RoLA Narcolepsy Treatment market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 49. RoLA Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 50. RoLA Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 51. Row Narcolepsy Treatment market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 52. Row Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 53. Row Narcolepsy Treatment market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 54. List of secondary sources, used in the study of global Narcolepsy Treatment market
TABLE 55. List of primary sources, used in the study of global Narcolepsy Treatment market
TABLE 56. Years considered for the study
TABLE 57. Exchange rates considered

LIST OF FIGURES

FIG 1. Global Narcolepsy Treatment market, research methodology
FIG 2. Global Narcolepsy Treatment market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Narcolepsy Treatment market, key trends 2021
FIG 5. Global Narcolepsy Treatment market, growth prospects 2022-2028
FIG 6. Global Narcolepsy Treatment market, porters 5 force model
FIG 7. Global Narcolepsy Treatment market, pest analysis
FIG 8. Global Narcolepsy Treatment market, value chain analysis
FIG 9. Global Narcolepsy Treatment market by segment, 2019 & 2028 (USD Billion)
FIG 10. Global Narcolepsy Treatment market by segment, 2019 & 2028 (USD Billion)
FIG 11. Global Narcolepsy Treatment market by segment, 2019 & 2028 (USD Billion)
FIG 12. Global Narcolepsy Treatment market by segment, 2019 & 2028 (USD Billion)
FIG 13. Global Narcolepsy Treatment market by segment, 2019 & 2028 (USD Billion)
FIG 14. Global Narcolepsy Treatment market, regional snapshot 2019 & 2028
FIG 15. North America Narcolepsy Treatment market 2019 & 2028 (USD Billion)
FIG 16. Europe Narcolepsy Treatment market 2019 & 2028 (USD Billion)
FIG 17. Asia pacific Narcolepsy Treatment market 2019 & 2028 (USD Billion)
FIG 18. Latin America Narcolepsy Treatment market 2019 & 2028 (USD Billion)
FIG 19. Global Narcolepsy Treatment market, company market share analysis (2021)


More Publications